“A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes”. 2025. Cardiology and Cardiovascular Medicine 9 (6): 491-98. https://fortunejournals.org/ojs/index.php/ccm/article/view/16664.